Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines
Perry, B., Alexander, R., Bennett, G., Buckley, G., Ceska, T., Crabbe, T., Dale, V., Gowers, L., Horsley, H., James, L., Jenkins, K., Crepy, K., Kulisa, C., Lightfoot, H., Lock, C., Mack, S., Morgan, T., Nicolas, A.-L., Pitt, W., Sabin, V., Wright, S.(2008) Bioorg Med Chem Lett 18: 4700-4704
- PubMed: 18644721 
- DOI: https://doi.org/10.1016/j.bmcl.2008.06.104
- Primary Citation of Related Structures:  
3DPD - PubMed Abstract: 
The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.
Organizational Affiliation: 
UCB, Medicinal Chemistry, Granta Park, Great Abington, Cambridge CB21 6GS, UK. bengperry@yahoo.co.uk